What it's for (Indications)
- Cholecalciferol, commonly known as Vitamin D3, is indicated for a range of conditions primarily involving vitamin D deficiency and related disorders of calcium and phosphate metabolism.
- Its primary use is in the **prevention and treatment of vitamin D deficiency**, a widespread public health issue that can lead to significant skeletal and extra-skeletal complications.
- It is also an essential therapeutic agent in the **management of metabolic bone diseases**, including **rickets in children and osteomalacia in adults**, both characterized by defective bone mineralization due to inadequate vitamin D, calcium, or phosphate.
- Furthermore, cholecalciferol is frequently prescribed as **adjuvant therapy for osteoporosis**, often in combination with calcium supplementation, to enhance bone mineral density, reduce bone turnover, and decrease the risk of fragility fractures, particularly in elderly populations.
- It plays a crucial role in maintaining calcium homeostasis, thus being beneficial in certain forms of **hypoparathyroidism** and managing features of **Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)** in earlier stages of kidney disease to prevent secondary hyperparathyroidism.
- The selection of dosage and duration of therapy depends on the severity of deficiency, patient age, and underlying medical conditions, always aiming for optimal serum 25-hydroxyvitamin D levels.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The dosage of cholecalciferol is highly individualized and must be determined by a healthcare professional based on the patient's age, baseline serum 25-hydroxyvitamin D (25(OH)D) levels, severity of deficiency, clinical indications, and renal function. For the **treatment of moderate to severe vitamin D deficiency in adults**, common regimens involve high-dose intermittent therapy, such as 50,000 International Units (IU) once weekly or 6,000 IU daily for 8 to 12 weeks, often followed by a lower maintenance dose. For **maintenance and prevention of deficiency in adults**, typical daily doses range from 600 IU to 2,000 IU, though some clinical guidelines recommend up to 4,000 IU daily to achieve and maintain optimal serum 25(OH)D concentrations (generally above 30 ng/mL or 75 nmol/L), especially in high-risk populations. Pediatric dosing is age- and weight-dependent, with infants typically receiving 400 IU daily for prevention. For children with deficiency, higher short-term doses are used. Regular monitoring of serum 25(OH)D, calcium, and phosphate levels is paramount during therapy, particularly when prescribing higher doses, to ensure efficacy and prevent the development of hypercalcemia or other adverse effects. |
Safety & Warnings
Common Side Effects
- Cholecalciferol is generally well-tolerated when administered within recommended physiological and therapeutic dosages.
- However, adverse effects predominantly arise from **hypervitaminosis D**, which occurs due to excessive intake, leading to elevated serum 25-hydroxyvitamin D levels and subsequent **hypercalcemia** (abnormally high blood calcium).
- Common symptoms associated with hypercalcemia include gastrointestinal disturbances such as nausea, vomiting, constipation, abdominal pain, and loss of appetite.
- Patients may also experience increased thirst (polydipsia), frequent urination (polyuria), fatigue, generalized muscle weakness, and headache.
- More serious and potentially life-threatening complications of severe hypercalcemia include acute renal impairment or chronic kidney disease due to nephrocalcinosis (calcium deposition in the kidneys) and kidney stone formation.
- Cardiac arrhythmias, hypertension, and mental status changes, ranging from confusion to stupor or coma, can also occur.
- Rarely, pancreatitis has been associated with severe hypercalcemia.
- Allergic reactions, such as rash, pruritus, or swelling, are infrequent but possible.
- Careful monitoring of serum calcium, phosphate, and 25(OH)D levels is crucial to prevent these adverse effects, especially when high doses are utilized.
Serious Warnings
- Black Box Warning: While cholecalciferol is generally safe at recommended physiological doses, **serious warnings are associated with its misuse or overdose, primarily concerning the development of hypervitaminosis D and subsequent hypercalcemia.** High doses of cholecalciferol, especially when administered over prolonged periods without appropriate medical supervision and laboratory monitoring, can lead to dangerously elevated levels of serum calcium. Hypercalcemia can manifest with a constellation of symptoms including nausea, vomiting, constipation, abdominal pain, polyuria, polydipsia, muscle weakness, fatigue, confusion, and in severe cases, stupor or coma. Prolonged hypercalcemia can result in irreversible soft tissue calcification, nephrocalcinosis leading to renal impairment or failure, kidney stones, and cardiac arrhythmias. Patients with pre-existing conditions such as sarcoidosis, other granulomatous diseases, or impaired renal function may be at increased risk of hypercalcemia and should receive cholecalciferol with extreme caution and frequent monitoring. Therefore, strict adherence to prescribed dosages and regular assessment of serum 25-hydroxyvitamin D, calcium, and phosphate levels are imperative to mitigate these serious risks.
- Several important warnings should be considered when prescribing cholecalciferol to ensure patient safety and optimize therapeutic outcomes.
- The most critical warning pertains to the **risk of hypercalcemia**, particularly when administering high doses or in susceptible individuals.
- Elevated serum calcium levels can lead to severe adverse effects on renal, cardiovascular, and nervous systems; therefore, regular monitoring of serum calcium, phosphorus, and 25-hydroxyvitamin D concentrations is essential during therapy.
- Patients with **impaired renal function** require cautious dosing and close surveillance due to altered calcium and phosphate handling, and the potential for nephrocalcinosis.
- Individuals with **granulomatous diseases**, such as sarcoidosis, tuberculosis, or histoplasmosis, are particularly sensitive to the effects of vitamin D due to unregulated extrarenal production of calcitriol, which can precipitate hypercalcemia even at lower doses, necessitating careful monitoring.
- Caution is also advised in patients with **pre-existing cardiac disease** or those receiving **cardiac glycosides**, as hypercalcemia can exacerbate arrhythmias or increase the risk of digitalis toxicity.
- Furthermore, clinicians must be aware of potential **drug interactions** with thiazide diuretics (increased hypercalcemia risk), phenytoin and barbiturates (may reduce vitamin D efficacy), and bile acid sequestrants (e.
- g.
- , cholestyramine) or mineral oil (may impair cholecalciferol absorption), which may necessitate dosage adjustments or alternative management strategies.
How it Works (Mechanism of Action)
Cholecalciferol, or Vitamin D3, is a prohormone that itself is biologically inactive. Its therapeutic action is initiated through a two-step hydroxylation process to form its active hormonal metabolite. Initially, cholecalciferol is absorbed from the gastrointestinal tract or synthesized in the skin upon exposure to ultraviolet B (UVB) radiation. It then undergoes its first hydroxylation in the liver by the enzyme 25-hydroxylase, converting it into 25-hydroxyvitamin D (calcifediol or 25(OH)D), which is the primary circulating form and the best indicator of vitamin D status. Subsequently, 25(OH)D is transported to the kidneys, where it undergoes a second hydroxylation by the enzyme 1-alpha-hydroxylase, producing 1,25-dihydroxyvitamin D (calcitriol or 1,25(OH)2D), the biologically active form of vitamin D. Calcitriol exerts its effects by binding to the widespread vitamin D receptor (VDR) found in numerous tissues, including the intestine, bone, kidney, and parathyroid glands. Its primary functions involve maintaining calcium and phosphate homeostasis by promoting their absorption from the small intestine, facilitating their reabsorption in the renal tubules, and regulating bone mineralization and remodeling processes. It also plays crucial roles in modulating immune function, cell proliferation, and differentiation, contributing to a wide array of physiological processes beyond bone health.